Stock Taper 
TEKLA CAPITAL MANAGEMENT LLC
Latest 13F filing data - Q2 2023
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Eli Lilly and Company | LLY | 213.35K | $100.06M |
 BioMarin Pharmaceutical Inc. | BMRN | 210.79K | $18.27M |
 UnitedHealth Group Incorporated | UNH | 206.96K | $99.47M |
 TScan Therapeutics, Inc. | TCRX | 200K | $500K |
 Vaxcyte, Inc. | PCVX | 194.23K | $9.7M |
 Edwards Lifesciences Corporation | EW | 189.6K | $17.88M |
 LTC Properties, Inc. | LTC | 182.29K | $6.02M |
 Smith & Nephew plc | SNN | 181.71K | $5.86M |
 Sarepta Therapeutics, Inc. | SRPT | 179.44K | $20.55M |
 Healthcare Realty Trust Incorporated | HR | 174.69K | $3.29M |
 Regeneron Pharmaceuticals, Inc. | REGN | 161.42K | $115.99M |
 Intellia Therapeutics, Inc. | NTLA | 154.27K | $6.29M |
 BridgeBio Pharma, Inc. | BBIO | 150.92K | $2.6M |
 Edgewise Therapeutics, Inc. | EWTX | 150.42K | $1.17M |
 Tenet Healthcare Corporation | THC | 149.07K | $12.13M |
 Arcutis Biotherapeutics, Inc. | ARQT | 148.87K | $1.42M |
 Jazz Pharmaceuticals plc | JAZZ | 147.78K | $18.32M |
 Alnylam Pharmaceuticals, Inc. | ALNY | 143.21K | $27.2M |
 Danaher Corporation | DHR | 142.81K | $34.28M |
 Ascendis Pharma A/S | ASND | 138.79K | $12.39M |